Platelet Rich Plasma Testis Treatment for Infertile Men
Launched by STANFORD UNIVERSITY · Jul 26, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new treatment option for men facing infertility, specifically those diagnosed with nonobstructive azoospermia, which means they have no sperm in their semen due to issues with sperm production. The researchers are investigating whether injecting a substance called platelet-rich plasma (PRP), derived from the patient's own blood, into the testicles can help improve the chances of retrieving sperm and achieving successful outcomes in in vitro fertilization (IVF). This study is particularly important for men who have previously undergone a sperm retrieval procedure called TESE but were unsuccessful.
To participate in this trial, men must be over 18 years old and have been diagnosed with nonobstructive azoospermia, along with at least one failed attempt at sperm retrieval. If you join the study, you can expect to receive the PRP injection and be monitored for its effects on sperm retrieval rates. The goal is to see if this treatment can provide hope for men who currently have limited options after unsuccessful sperm retrieval attempts. If you are interested, the trial is currently recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy
- Exclusion Criteria:
- • -
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials